Ion Channels

Ion Channels

The Ion Channel Database is the Aureus Sciences' knowledge base containing voltage and ligand-gated ion channels, ligand-relevant chemical information associated with quantitative biological activities and mechanisms of action.

All chemical and bioactivity data are organized in an Oracle database according to the Aureus relational data model.

        Main Features
    • Structure-activity data culled from international scientific journals and patents (US, Euro & international)
    • All ion channel targets: voltage-gated, ligand-gated channels and other families
    • Detailed descriptions of the experimental methods and conditions used to generate activity data points
    • Data organized in relational tables according to: chemical information, protein target information, bioactivity and experimental methods
      AurSCOPE Ion Channels Database Protocols
      Uses
      Medicinal chemists, cheminformaticians, pharmacologists and biologists use the knowledge base to:
    • Retrieve ligands tested as blockers, openers or activators of an ion channel
    • Retrieve selective molecules for a specific ion channel vs. another
    • Assess ligands’ mechanism of action, study structure activity relationships to guide compound optimization
    • Access in vitro and in vivo pharmacological activity data, materials and methods used
    • Search records via text and numeric queries (biological activity and biological data field searches)
    • Export data to SD files, .txt and .xls formats

      Chemical Information
    • Registered ligands always associated with at least one quantitative experimental biological data
    • Compound descriptions including structure, name, synonyms, pharmaceutical codes, therapeutic class, calculated physicochemical parameters and SMILES
    • Druggability assessments using graphical representation based on Lipinski/Weber rules

      Protein Target Information
    • Hierarchically organized ion channel target by names, acronyms and synonyms
    • Target descriptions including species, action site and transfection method
    • Channel subunit composition and stoechiometry as appropriate
    • Links to Uniprot (SwissProt), GenBank and Protein Data Bank (PDB) where available
    • Mutated targets described with mutation details

      Bioactivity and Experimental Methods
    • Detailed biological material descriptions (species, tissue, cell, etc.)
    • Extensive in vitro (binding, flux, electrophysiology, cell behavior, isolated organs) and in vivo experimental methods
    • Drug target selectivity
    • Ligands classified according to functional activities (inhibitor, stimulator, allosteric modulator, etc..)
    • In vivo protocols described by all experimental model details and compound route of administration
    • Pharmacokinetics data where appropriate
    • All activity data points with normalized parameters and units
    • Reference to the journals, patents and links to PubMed and Espacenet

      Semantics and Quality Controls
    • Standardized Thesauri, Glossaries, Ontology Management-based process with hierarchies
    • All registered data updated regularly utilizing validated Glossaries/Thesauri
    • Specialized quality control at every production step
    • Databases updated and released every three months

    Top